Pancreatic β-cell loss through apoptosis is an important disease mechanism in type 2 diabetes. Apoptosis Repressor with CARD (ARC) is a cell death inhibitor that antagonizes multiple death programs. We previously reported that ARC is abundant in pancreatic β-cells and modulates survival of these cells in vitro. Herein we assessed the importance of endogenous ARC in maintaining islet structure and function in vivo. While generalized loss of ARC did not result in detectable abnormalities, its absence in ob/ob mice, a model of type 2 diabetes, induced a striking pancreatic phenotype: marked β-cell death, loss of β-cell mass, derangements of islet architecture, and impaired glucose-stimulated insulin secretion in vivo. These abnormalities contributed to worsening of hyperglycemia and glucoseintolerance in these mice. Mechanistically, the absence of ARC increased levels of C/EBP homologous protein (CHOP) in wild type isolated islets stimulated with ER stress and in ob/ob isolated islets at baseline. Deletion of CHOP in ob/ob; ARC −/− mice led to reversal of β-cell death and abnormalities in islet architecture. These data indicate that suppression of CHOP by endogenous levels of ARC is critical for β-cell viability and maintenance of normal islet structure in this model of type 2 diabetes.
deletion of caspase-8 in the death receptor pathway 7 or overexpression of Bcl-2 8 , an inhibitor of mitochondrial apoptogen release, both protect against diabetes. However, the alterations in death signaling that actually mediate the natural pathogenesis of this syndrome are poorly understood.
Cell death pathways are under negative as well as positive control. ARC (Apoptosis Repressor with CARD (Caspase Recruitment Domain)) is an endogenous inhibitor of cell death that was initially thought to be restricted to cardiac and skeletal myocytes and some neuronal populations 9, 10 . More recent work, however, has shown that ARC expression is induced in multiple cancers [11] [12] [13] , and that it is abundant at baseline in human and mouse β-cells in vivo 14 . While most cell death inhibitors target a single pathway, ARC antagonizes both central death pathways through protein-protein interactions involving its CARD 15 . Inhibition of the death receptor pathway is mediated through direct interactions of ARC with the death receptor Fas and with its adaptor protein FADD, which preclude assembly of the DISC. ARC suppresses the mitochondrial-ER pathway by direct binding to Bax, which blocks Bax conformational activation.
We previously employed gain and loss of function approaches using in vitro systems to define an inhibitory role for ARC in β-cell death elicited by ER stressors and lipotoxicity 14 . Given the complexity of diabetes and the possibility of redundancy among multiple cell death inhibitors, however, we wished to assess the role of ARC in vivo. Using a series genetic mouse models, we now report that ARC is critical not only for β-cell survival during type 2 diabetes but also for maintenance of islet structure in vivo. Moreover, ARC-mediated suppression of the ER stress mediator C/EBP homologous protein (CHOP) underlies these effects. (f) Hematoxylin and eosin (H&E) staining of pancreatic tissue. Scale bar 50 μM. No statistically significant differences were observed. This experiment was repeated in a second independent cohort of mice with similar results.
Results
Deletion of ARC does not result in baseline abnormalities in pancreatic structure or hyperglycemia. We had previously generated mice with germ line deletion of the entire open reading frame for ARC encoded by the Nol3 gene 16, 17 and, for clarity, will refer to homozygous knockouts as ARC −/−. Immunostaining confirmed the absence of ARC protein in pancreatic islets of knockout mice ( Fig. 1a ), as we have shown previously for other tissues in which ARC is normally expressed 16, 17 . Wild type and ARC −/− mice were indistinguishable with respect to body weights, fasting and non-fasting blood glucose concentrations, glucose tolerance, and pancreatic histology ( Fig. 1b-f ). These data indicate that ARC is not required for normal pancreatic structure or glucose homeostasis under basal conditions. ARC is essential for β-cell viability and islet structure in a diabetic context. To assess the importance of ARC in β-cell survival under the stressed conditions of type 2 diabetes, we crossed ARC −/− mice with ob/ob mice, a leptin deficient line that exhibits obesity and type 2 diabetes. The absence of ARC on the ob/ob background resulted in marked disorganization in islet architecture compared to control animals ( Fig. 2a ). Whereas ob/ob; ARC +/+ mice had a ratio of 2:1 normal to abnormal islets, ob/ob; ARC −/− had equal numbers of abnormal and normal islets ( Fig. 2b ). Diabetic mice lacking ARC also had a significant decrease in β-cell mass (Fig. 2c) , a difference not explained by changes in the rates of β-cell proliferation (Fig. 2d ). In contrast, there was a 4-fold increase in rates of apoptosis as assessed by TUNEL ( Fig. 2e ) and immunostaining for cleaved (active) caspase-3 ( Fig. 2f ). These data indicate that, in the ob/ob context, ARC is essential for β-cell survival and maintenance of normal islet structure.
We also characterized the metabolic phenotype of ob/ob; ARC −/− mice. Loss of ARC did not affect body weight or fasting plasma glucose concentrations, but non-fasting blood glucose levels were markedly and persistently elevated starting at 11 weeks of age as was food intake ( Fig. 3a-d ). Deletion of ARC also impaired glucose tolerance ( Fig. 3e ). While both ob/ob; ARC +/+ and ob/ob; ARC −/− mice exhibited severe insulin resistance as demonstrated by the need to employ a high dose of insulin (5 U/kg) to decrease blood glucose concentrations, deletion of ARC exacerbated this abnormality to only a minor degree ( Fig. 3f ). Importantly, consistent with the loss of β-cell mass in ob/ob; ARC −/− mice ( Fig. 2c ), glucose-stimulated secretion of insulin and C-reactive peptide was impaired compared with ob/ob; ARC +/+ mice ( Fig. 3g and h).
ARC maintains β-cell viability and islet architecture through suppression of CHOP induction. ER stress is a major component in the pathogenesis of type 2 diabetes 18, 19 , and induction of the ER stress mediator CHOP has been implicated in β-cell death 20, 21 . We previously demonstrated in cultured β-cells that overexpression of ARC blunts the accumulation of CHOP in response to ER stressors 14 . To assess whether endogenous levels of ARC suppress the accumulation of CHOP, we treated islets isolated from ARC +/+ and ARC −/− animals not carrying the ob/ob mutation with thapsigargin to induce ER stress. Loss of ARC resulted in increased induction of CHOP (Fig. 4a ). Moreover, islets isolated from ob/ob; ARC −/− mice exhibited marked elevations in CHOP at baseline compared with islets isolated from ob/ob; ARC +/+ mice (Fig. 4b) . These data demonstrate that endogenous ARC suppresses CHOP levels. To determine whether the observed derangements in islet tissue architecture and β-cell death resulting from ARC absence are mediated by CHOP, we generated ob/ob; ARC −/−; CHOP −/− mice. The absence of CHOP rescued both the islet disorganization and β-cell death ( Fig. 4c-f ). We conclude that endogenous levels of ARC maintain β-cell survival and islet structure in ob/ob mice through suppression of CHOP.
Discussion
While ARC knockdown renders cultured β-cells and isolated islets more susceptible to stress-induced death in vitro 14 , loss of function phenotypes in vitro sometimes do not persist in the more complex in vivo environment because of redundancy from functionally similar molecules. Despite the expression of other cell death inhibitors in vivo 8, 22 , we found that ARC is essential for β-cell survival in islets of ob/ob mice, although it is dispensable under non-stressed conditions. Further, the absence of ARC in ob/ob mice resulted in unexpected derangement of islet architecture. While our data show that both β-cell apoptosis and changes in islet architecture are CHOP-dependent, the mechanistic relationship of these two processes remains unclear. Although they may occur in parallel, it is intriguing to consider that one may be upstream of the other. For example, cell death-related alterations in β-cell structure or secretion might remodel surrounding tissue organization and/or, conversely, disruption of tissue organization could deprive β-cells of critical survival signals. For example, although only mildly dampened, decreases in insulin sensitivity in ob/ob; ARC −/− mice may be one such factor and could reflect loss of ARC in skeletal muscle and fat -but likely not liver where ARC expression is not detected even in wild type mice 10, 23 . In addition, hyperphagia may contribute to the fed hyperglycemia and be related to loss of ARC in neuronal populations that are known to be involved with appetite 24 . The generation of mice with a floxed Nol3 allele will be necessary to dissect contributions to the hyperglycemia from various tissues.
ARC overexpression blunts the induction of CHOP in cultured β-cells challenged with experimental and physiological ER stressors 14 . The current study reveals that loss of endogenous levels of ARC results in marked increases in CHOP in wild type islets stimulated with ER stress or even, at baseline, in islets obtained from ob/ob mice. Taken together with previous work linking CHOP with β-cell apoptosis 20, 21 , the rescue of β-cell death and islet structural abnormalities resulting from loss of ARC indicates that endogenous ARC protects against these phenotypes by suppressing CHOP during type 2 diabetes.
Methods
Mice. All mice were back bred >6 generations onto a C57BL/6J background. We previously generated germ line ARC −/− mice 16, 17 . ob/ob and CHOP −/− mice were purchased from Jackson Laboratories (Bar Harbor, Metabolic characterization of mice. Blood glucose concentrations were measured in mice fed ad libitum or after an overnight fast using OneTouch glucose monitoring system (LifeScan). For glucose tolerance tests (GTT), mice were injected with 2 g glucose/kg body weight after an overnight fast and blood glucose concentrations measured. For glucose-induced insulin secretion (GIIS), plasma insulin and C-peptide concentrations were measured by ELISA (ALPCO Diagnostics) following GTT. For insulin tolerance test (ITT), mice were injected with 5 U insulin/kg body weight after a 6 h fast.
Immunohistochemistry and quantification. Pancreatic tissue was prepared and stained as previously described 14 . Primary antibodies were ARC (Cayman Chemical), insulin (Abcam), BrdU (Roche), cleaved caspase-3 (Cell Signaling Technology), and α-tubulin (Sigma-Aldrich). Alexa Fluor 488 and 568 (Invitrogen) of corresponding species were used for recognition of primary antibodies. All images were collected with Axio Observer.Z1 microscope (Zeiss). Islet morphology was designated as abnormal if >25% of perimeter was jagged on hematoxylin and eosin-stained sections. All islets (~85-100) in pancreatic section were scored. β-cell area was determined by calculating the number of β-cell nuclei (insulin-positive cells) in an islet divided by the respective islet area (quantified with ImageJ; National Institutes of Health). A minimum of five islets were scored per mouse. For BrdU staining, BrdU 2.2 mg/ml was included in the drinking water for 4 days prior to sacrifice, and tissue sections were treated with 2 M HCl for 10 minutes at room temperature immediately following antigen retrieval. TUNEL staining was performed as previously described 14 . Slides were coverslipped with VECTASHIELD mounting media with DAPI (Vector Laboratories).
Immunoblotting. Procedures for isolated islets are as previously described 14 . After isolation of islets by collagenase digestion, lysates were digested by rotation in single lysis buffer. Primary antibodies included ARC (Cayman Chemical), GADD153 (CHOP) (Santa Cruz Biotechnology, F-168), and α-tubulin (Sigma-Aldrich). Secondary antibodies included IRDye 800 and 680 (LI-COR). Membranes were scanned using a LI-COR Odyssey and images quantified with ImageJ.
Statistics. Data are presented as mean ± SEM. For comparisons between two groups, a two-tailed student's t-test was performed. Multiple comparisons were analyzed using analysis of variance followed by a Tukey post-hoc test. For metabolic measurements, area under the curve was calculated followed by a two-tailed student's t-test. GraphPad Prism 5 software (La Jolla, CA) was used for calculations. P < 0.05 was deemed significant. Data availability. Data generated or analyzed during this study are included in this published article.
